Buy Rating Affirmed for Lineage Cell Therapeutics Amid Strategic Partnerships and Pipeline Progress
Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
Lineage Cell Therapeutics: A Buy Rating Amidst Financial Stability and Promising Clinical Progress
Analysts Are Bullish on These Healthcare Stocks: Lineage Therap (LCTX), Ironwood Pharma (IRWD)
Express News | Lineage Cell Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Express News | Lineage Cell Therapeutics Inc: Cash Expected to Support Planned Operations Into Q4 2025
Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Posts Q2 Revenue $1.4M, Vs. Street Est of $0.8M
Lineage Cell Therapeutics GAAP EPS of -$0.03 Beats by $0.01, Revenue of $1.4M Beats by $0.61M
Press Release: Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Express News | Ndustrial Receives U.S. Doe Grant to Enhance AI for Industrial Markets in Partnership With Lineage, Abb and Nrel
Lineage Cell Therapeutics Q2 2024 Earnings Preview
Lineage Receives Investment Grade Credit Ratings From Moody's and Fitch
Express News | Lineage Inc - on July 26, Repaid in Full Senior Unsecured Term Loan Facility With Aggregate Principal Balance of About $2.4 Bln
Express News | Lineage Announces $100M Investment in Its US Workforce via IPO Awards and Ongoing Grants Under Its Employee Equity Incentive Plan
Express News | Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
IPO Roundup: Pershing Square, Actuate Therapeutics and More
Lineage Announces Full Exercise of the Underwriters' Option to Purchase Additional Shares, Increasing Gross Proceeds to $5.1 Billion
Insider Buying: CFO Robert Crisci Acquires Shares of Lineage Inc (LINE)
Director Nancy Falotico Acquires 1,300 Shares of Lineage Inc (LINE)
Director Lynn Wentworth Acquires 3,100 Shares of Lineage Inc (LINE)
No Data